If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesco Galimi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Colorectal Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Oncogenes Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
1-Phosphatidylinositol 4-Kinase Medicine & Life Sciences
Cells Chemical Compounds
Growth Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours

Martin, V., Chiriaco, C., Modica, C., Acquadro, A., Cortese, M., Galimi, F., Perera, T., Gammaitoni, L., Aglietta, M., Comoglio, P. M., Vigna, E. & Sangiolo, D., Mar 2019, In : British Journal of Cancer. 120, 5, p. 527-536 10 p.

Research output: Contribution to journalArticle


Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer

Isella, C., Brundu, F., Bellomo, S. E., Galimi, F., Zanella, E., Porporato, R., Petti, C., Fiori, A., Orzan, F., Senetta, R., Boccaccio, C., Ficarra, E., Marchionni, L., Trusolino, L., Medico, E. & Bertotti, A., May 31 2017, In : Nature Communications. 8, 15107.

Research output: Contribution to journalArticle

Colorectal Neoplasms

HER2 activating mutations are targets for colorectal cancer treatment

Kavuri, S. M., Jain, N., Galimi, F., Cottino, F., Leto, S. M., Migliardi, G., Searleman, A. C., Shen, W., Monsey, J., Trusolino, L., Jacobs, S. A., Bertotti, A. & Bose, R., Aug 1 2015, In : Cancer Discovery. 5, 8, p. 832-841 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Protein-Tyrosine Kinases
erbB-2 Genes
Epidermal Growth Factor Receptor
Colorectal Neoplasms
Tumor Biomarkers

Intrinsic resistance to MEK inhibition in kras mutant lung and colon cancer through transcriptional induction of ERBB3

Sun, C., Hobor, S., Bertotti, A., Zecchin, D., Huang, S., Galimi, F., Cottino, F., Prahallad, A., Grernrum, W., Tzani, A., Schlicker, A., Wessels, L. F. A., Smit, E. F., Thunnissen, E., Halonen, P., Lieftink, C., Beijersbergen, R. L., DiNicolantonio, F., Bardelli, A., Trusolino, L. & 1 others, Bernards, R., Oct 4 2014, In : Cell Reports. 7, 1, p. 86-93 8 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
Colonic Neoplasms
Lung Neoplasms
Receptor Protein-Tyrosine Kinases